83_FR_12455 83 FR 12400 - Office of the Secretary; Notice of Meeting

83 FR 12400 - Office of the Secretary; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 55 (March 21, 2018)

Page Range12400-12400
FR Document2018-05739

Federal Register, Volume 83 Issue 55 (Wednesday, March 21, 2018) 
[Federal Register Volume 83, Number 55 (Wednesday, March 21, 2018)]
[Notices]
[Page 12400]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-05739]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Secretary; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Muscular Dystrophy 
Coordinating Committee (MDCC).
    The meeting will be open to the public and accessible by live 
webcast. Attendance is limited to space available. Individuals who plan 
to attend and need special assistance, such as sign language 
interpretation or other reasonable accommodations, should notify the 
Contact Person listed below in advance of the meeting.

    Name of Committee: Muscular Dystrophy Coordinating Committee.
    Type of Meeting: Open Meeting.
    Date: April 30, 2018.
    Time: 8:30 a.m. to 4:30 p.m. * Eastern Time *--Approximate end 
time.
    Agenda: The purpose of this meeting is to bring together 
committee members, representing government agencies, patient 
advocacy groups, other voluntary health organizations, and patients 
and their families to update one another on progress relevant to the 
Action Plan for the Muscular Dystrophies and to coordinate 
activities and discuss gaps and opportunities leading to better 
understanding of the muscular dystrophies, advances in treatments, 
and improvements in patients' and their families' lives. Prior to 
the meeting, an agenda will be posted to the MDCC meeting 
registration website: https://meetings.ninds.nih.gov/?ID=19167.
    Registration: To register, please go to: https://meetings.ninds.nih.gov/?ID=19167.
    Webcast Live: For those not able to attend in person, this 
meeting will be webcast at: http://videocast.nih.gov/.
    Place: National Institutes of Health, Neuroscience Center, 
Conference Room C/D, 6001 Executive Boulevard, Rockville, Maryland 
20852.
    Contact Person: Glen H. Nuckolls, Ph.D., Executive Secretary, 
Muscular Dystrophy Coordinating Committee, National Institute of 
Neurological Disorders and Stroke, NIH, 6001 Executive Boulevard, 
NSC 2203, Bethesda, MD 20892, (301) 496-5745, 
[email protected].

    Any member of the public interested in presenting oral comments 
to the committee may notify the Contact Person listed on this notice 
at least 10 days in advance of the meeting. Interested individuals 
and representatives of organizations may submit a letter of intent, 
a brief description of the organization represented, and a short 
description of the oral presentation. Only one representative of an 
organization may be allowed to present oral comments and if accepted 
by the committee, presentations may be limited to five minutes. Both 
printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
committee by forwarding their statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    All visitors must go through a security check at the building 
entrance to receive a visitor's badge. A government issued photo ID 
is required. Further information can be found at the registration 
website: https://meetings.ninds.nih.gov/?ID=19167.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS)

    Dated: March 16, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-05739 Filed 3-20-18; 8:45 am]
 BILLING CODE 4140-01-P

12400 Federal Register / Vol. 83, No. 55 / Wednesday, March 21, 2018 / Notices 20892, 301–435–0809, anna.ramseyewing@ Place: National Institutes of Health, 6701 Date: April 30, 2018. nih.gov. Rockledge Drive, Bethesda, MD 20892 Time: 8:30 a.m. to 4:30 p.m. * Eastern Name of Committee: National Center for (Telephone Conference Call). Time *—Approximate end time. Advancing Translational Sciences Advisory Contact Person: Robert Freund, Ph.D., Agenda: The purpose of this meeting is to Council. Scientific Review Officer, Center for bring together committee members, Date: May 10, 2018. Scientific Review, National Institutes of representing government agencies, patient Open: 8:30 a.m. to 3:00 p.m. Health, 6701 Rockledge Drive, Room 5216, advocacy groups, other voluntary health Agenda: Report from the Institute Director MSC 7852, Bethesda, MD 20892, 301–435– organizations, and patients and their families and other staff. 1050, freundr@csr.nih.gov. to update one another on progress relevant to Place: National Institutes of Health, This notice is being published less than 15 the Action Plan for the Muscular Dystrophies Building 31, Conference Room 10, 31 Center days prior to the meeting due to the timing and to coordinate activities and discuss gaps Drive, Bethesda, MD 20892. limitations imposed by the review and and opportunities leading to better Closed: 3:15 p.m. to 4:30 p.m. funding cycle. understanding of the muscular dystrophies, Agenda: To review and evaluate grant Name of Committee: Center for Scientific advances in treatments, and improvements in applications. Review Special Emphasis Panel; Topics in patients’ and their families’ lives. Prior to the Place: National Institutes of Health, Metabolism. meeting, an agenda will be posted to the Building 31, Conference Room 10, 31 Center Date: March 27, 2018. MDCC meeting registration website: https:// Drive, Bethesda, MD 20892. Time: 2:30 p.m. to 3:30 p.m. meetings.ninds.nih.gov/?ID=19167. Contact Person: Anna L. Ramsey-Ewing, Agenda: To review and evaluate grant Registration: To register, please go to: Ph.D., Executive Secretary, National Center applications. https://meetings.ninds.nih.gov/?ID=19167. for Advancing Translational Sciences, 1 Place: National Institutes of Health, 6701 Webcast Live: For those not able to attend Democracy Plaza, Room 1072, Bethesda, md Rockledge Drive, Bethesda, MD 20892 in person, this meeting will be webcast at: 20892, 301–435–0809, anna.ramseyewing@ (Telephone Conference Call). http://videocast.nih.gov/. nih.gov. Contact Person: Liliana N. Berti-Mattera, Place: National Institutes of Health, Ph.D., Scientific Review Officer, Center for Neuroscience Center, Conference Room C/D, (Catalogue of Federal Domestic Assistance Scientific Review, National Institutes of 6001 Executive Boulevard, Rockville, Program Nos. 93.859, Pharmacology, Health, 6701 Rockledge Drive, RM 4215, Maryland 20852. Physiology, and Biological Chemistry Bethesda, MD 20892, 301–827–7609, Contact Person: Glen H. Nuckolls, Ph.D., Research; 93.350, B—Cooperative liliana.berti-mattera@nih.gov. Executive Secretary, Muscular Dystrophy Agreements; 93.859, Biomedical Research This notice is being published less than 15 Coordinating Committee, National Institute and Research Training, National Institutes of days prior to the meeting due to the timing of Neurological Disorders and Stroke, NIH, Health, HHS) limitations imposed by the review and 6001 Executive Boulevard, NSC 2203, Dated: March 15, 2018. Bethesda, MD 20892, (301) 496–5745, funding cycle. David Clary, glen.nuckolls@ninds.nih.gov. (Catalogue of Federal Domestic Assistance Program Analyst, Office of Federal Advisory Program Nos. 93.306, Comparative Medicine; Any member of the public interested in Committee Policy. 93.333, Clinical Research, 93.306, 93.333, presenting oral comments to the committee [FR Doc. 2018–05736 Filed 3–20–18; 8:45 am] 93.337, 93.393–93.396, 93.837–93.844, may notify the Contact Person listed on this 93.846–93.878, 93.892, 93.893, National notice at least 10 days in advance of the BILLING CODE 4140–01–P Institutes of Health, HHS) meeting. Interested individuals and representatives of organizations may submit Dated: March 15, 2018. a letter of intent, a brief description of the DEPARTMENT OF HEALTH AND David Clary, organization represented, and a short HUMAN SERVICES Program Analyst, Office of Federal Advisory description of the oral presentation. Only one Committee Policy. representative of an organization may be National Institutes of Health allowed to present oral comments and if [FR Doc. 2018–05733 Filed 3–20–18; 8:45 am] accepted by the committee, presentations Center for Scientific Review; Notice of BILLING CODE 4140–01–P may be limited to five minutes. Both printed Closed Meetings and electronic copies are requested for the record. In addition, any interested person Pursuant to section 10(d) of the DEPARTMENT OF HEALTH AND may file written comments with the Federal Advisory Committee Act, as HUMAN SERVICES committee by forwarding their statement to amended, notice is hereby given of the the Contact Person listed on this notice. The following meetings. National Institutes of Health statement should include the name, address, telephone number and when applicable, the The meetings will be closed to the Office of the Secretary; Notice of business or professional affiliation of the public in accordance with the Meeting interested person. provisions set forth in sections All visitors must go through a security 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Pursuant to section 10(d) of the check at the building entrance to receive a as amended. The grant applications and Federal Advisory Committee Act, as visitor’s badge. A government issued photo the discussions could disclose amended, notice is hereby given of a ID is required. Further information can be confidential trade secrets or commercial meeting of the Muscular Dystrophy found at the registration website: https:// Coordinating Committee (MDCC). meetings.ninds.nih.gov/?ID=19167. property such as patentable material, and personal information concerning The meeting will be open to the (Catalogue of Federal Domestic Assistance public and accessible by live webcast. Program Nos. 93.853, Clinical Research individuals associated with the grant Related to Neurological Disorders; 93.854, applications, the disclosure of which Attendance is limited to space available. Individuals who plan to attend and Biological Basis Research in the would constitute a clearly unwarranted Neurosciences, National Institutes of Health, need special assistance, such as sign sradovich on DSK3GMQ082PROD with NOTICES invasion of personal privacy. HHS) language interpretation or other Name of Committee: Center for Scientific reasonable accommodations, should Dated: March 16, 2018. Review Special Emphasis Panel; PAR Panel: notify the Contact Person listed below Sylvia L. Neal, AIDS and AIDS Related Research. Date: March 21, 2018. in advance of the meeting. Program Analyst, Office of Federal Advisory Committee Policy. Time: 1:00 p.m. to 5:00 p.m. Name of Committee: Muscular Dystrophy Agenda: To review and evaluate grant Coordinating Committee. [FR Doc. 2018–05739 Filed 3–20–18; 8:45 am] applications. Type of Meeting: Open Meeting. BILLING CODE 4140–01–P VerDate Sep<11>2014 18:34 Mar 20, 2018 Jkt 244001 PO 00000 Frm 00068 Fmt 4703 Sfmt 9990 E:\FR\FM\21MRN1.SGM 21MRN1


Document Created: 2018-03-21 00:45:26
Document Modified: 2018-03-21 00:45:26
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesApril 30, 2018.
FR Citation83 FR 12400 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR